Augmedics is currently a pioneer when it comes to augmented reality technology that can be used when performing surgery. The firm has held fundraisers over the years, and during the recent one, they managed to raise $36 million. As an executive at Augmedics, Tim Murawski has played a key role in the success of the firm, considering he understands the importance of innovation. Some of the innovations by Augmedics have caught the attention of investors, such as Revival Healthcare Capital, Almeda Ventures, among others. 


Amid the Covid-19  pandemic, investor activity was brought to a halt. There has also been a delay when it comes to treatments such as spine surgery. As a result, Augmedics has been forced to look into other ways to launch its products. Augmedics was happy to announce that the xvision Spine System (XVS) has been cleared by the FDA (Food and Drug Administration). According to Tim Murawski, it’s the only surgical image guidance system that has been approved by the FDA so far, and it makes use of augmented reality.


To date, the system has been used to carry out numerous spine procedures. Augmedics medical research firm is set to raise more funds that will come in handy as the company explores new markets. The main focus is on ensuring that people can gain confidence in technology, primarily when it is being used during spinal surgery. As a medic, Tim Muarwski explains, you can use the xvision spine system to visualize the spine in 3D, which means you can perform surgery with utmost accuracy. Under the tenure of Tim Murawski, Augmedics is set to grow further. Murawski has proven he’s an able and capable leader, and Augmedics is in good hands.

More on Tim Murawski´s biography and career at